The Asia Pacific Aneurysm Clips Market would witness market growth of 8.1% CAGR during the forecast period (2022-2028).
Microsurgical clipping has become one of the ideal treatment methods to obstruct the intracranial aneurysm. Currently, the clinical application of the latest developed and commercially accessible titanium cerebral aneurysmal clips in treating patients with aneurysmal has displayed their biocompatibility, effectiveness to reduce clip artifacts on MRI 3-fold.
These benefits of the titanium cerebral aneurysmal clips over the conventional clips have increased their utilization in the surgery of aneurysms. Brain aneurysms could occur at any age and to anyone. Although, they are most common in adults between the years of 30 and 60 and occur more in females than in males. People with specific inherited diseases are at a higher risk of developing aneurysm.
Cerebral aneurysms could occur due to inherited risk factors, comprising genetic connective tissue diseases that weaken the artery walls, arteriovenous malformations, and polycystic kidney disease. Some AVMs grow sporadically or by themselves owing to a past aneurysm in a first-degree family member, i.e., parent, sibling, or child.
In India, studies predicted that the prevalence of stroke population lay between 116 to 163 per 100,000 people. In the recent past, the ICMR (Indian Council of Medical Research) has presented a report, “India: Health of the Nation’s States,” as per which; in 2016, stroke was the fourth leading source of death and the fifth leading cause of DALY (Disability Adjusted Life Years). With the introduction of Ayushman Bharat in 2018, it is predicted that all primary health centers and health sub-center would be upgraded as Health and Wellness Centers provide an extensive range of primary healthcare facilities. This comprises promotive, preventive, rehabilitative, and curative aspects of a broad range of facilities, including treatment for the whole population. This will lead to the growth of the aneurysm clips market in the upcoming years.
The China market dominated the Asia Pacific Aneurysm Clips Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8,190.5 Thousands by 2028. The Japan market is estimated to grow a CAGR of 7.4% during (2022 - 2028). Additionally, The India market would experience a CAGR of 8.7% during (2022 - 2028).
Based on Material, the market is segmented into Titanium Aneurysm Clips, Polymer and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on Indication, the market is segmented into Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Aneurysm Clips Market is Projected to reach USD 102.9 Million by 2028, at a CAGR of 7.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Stryker Corporation, Integra LifeSciences Holdings Corporation, Boston Scientific Corporation, B. Braun Melsungen AG (Aesculap, Inc.), Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences), KLS Martin Group, Adeor Medical AG, and Evonos GmbH & Co.KG.
By Material
By End-use
By Indication
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 